|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0014257,
umls-concept:C0021368,
umls-concept:C0025598,
umls-concept:C0029161,
umls-concept:C0030705,
umls-concept:C0038766,
umls-concept:C0050393,
umls-concept:C0071097,
umls-concept:C0332293,
umls-concept:C1280500
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-9-13
|
|
pubmed:abstractText |
WHAT IS KNOWN: The increased risk of cardiovascular events in diabetic patients has been related to numerous metabolic and haemoreological factors. Some of these factors appear to be particularly evident during the post-prandial phases and to be related to peak plasma glucose level.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acarbose,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Metformin,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1365-2710
|
|
pubmed:author |
pubmed-author:CiceroA F GAF,
pubmed-author:D'AngeloAA,
pubmed-author:DerosaGG,
pubmed-author:FerrariII,
pubmed-author:FogariEE,
pubmed-author:GravinaAA,
pubmed-author:MaffioliPP,
pubmed-author:MereuRR,
pubmed-author:PalumboII,
pubmed-author:RandazzoSS,
pubmed-author:SalvadeoS ASA
|
|
pubmed:copyrightInfo |
Copyright © 2010 Blackwell Publishing Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
565-79
|
|
pubmed:meshHeading |
pubmed-meshheading:20831680-Acarbose,
pubmed-meshheading:20831680-Biological Markers,
pubmed-meshheading:20831680-Blood Glucose,
pubmed-meshheading:20831680-Blood Pressure,
pubmed-meshheading:20831680-Body Mass Index,
pubmed-meshheading:20831680-Diabetes Mellitus, Type 2,
pubmed-meshheading:20831680-Female,
pubmed-meshheading:20831680-Glucose Tolerance Test,
pubmed-meshheading:20831680-Hemoglobin A, Glycosylated,
pubmed-meshheading:20831680-Humans,
pubmed-meshheading:20831680-Hypoglycemic Agents,
pubmed-meshheading:20831680-Inflammation,
pubmed-meshheading:20831680-Interleukin-6,
pubmed-meshheading:20831680-Lipids,
pubmed-meshheading:20831680-Male,
pubmed-meshheading:20831680-Metformin,
pubmed-meshheading:20831680-Middle Aged,
pubmed-meshheading:20831680-Sulfonylurea Compounds,
pubmed-meshheading:20831680-Thiazolidinediones,
pubmed-meshheading:20831680-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin.
|
|
pubmed:affiliation |
Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuseppe.derosa@unipv.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
